Tata India Pharma & Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1 %Nav, as on 26-05-2023

  • Previous Nav

  • Net Change on 26-05-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 2.87 5.16 6.97 15.35 15.41 7.23
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 6.97 15.35 15.41 2.42 512.42
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 7.82 16.23 16.07 1.93 4,510.77
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 15.62 18.82 15.72 2.18 1,637.91
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 5.20 13.97 13.63 2.45 682.85

Fund Holdings as on 30-April-2023

  • SUN PHARMACEUTICAL INDUSTRIES LTD

  • CIPLA LTD

  • DR REDDYs LABORATORIES LTD

  • LUPIN LTD

  • ALKEM LABORATORIES LTD

  • DIVI LABORATORIES LTD

  • FORTIS HEALTHCARE LTD

  • AUROBINDO PHARMA LTD

  • A) REPO

  • APOLLO HOSPITALS ENTERPRISE LTD

  • HEALTHCARE GLOBAL ENTERPRISES LTD

  • FDC LTD

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

  • IPCA LABORATORIES LTD

  • ZYDUS LIFESCIENCES LTD

  • GLENMARK PHARMACEUTICALS LTD

  • INDOCO REMEDIES LTD

  • GLAND PHARMA LTD

  • ASTER DM HEALTHCARE LTD

  • MANKIND PHARMA LTD

  • AJANTA PHARMA LTD

  • PROCTER & GAMBLE HEALTH LTD

  • MEDPLUS HEALTH SERVICES LTD

  • ABBOTT INDIA LTD

  • TORRENT PHARMACEUTICALS LTD

  • SYNGENE INTERNATIONAL LTD

  • CASH / NET CURRENT ASSET

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD

  • SANOFI INDIA LTD

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

  • Cash

  • Equity

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹512.42 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended up ₹0.17(1%)yesterday to ₹16.7732.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and

The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty .

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

+91 (22) 66578282
kiran@tataamc.com
+91 (22) 22613782